Ontology highlight
ABSTRACT:
SUBMITTER: Parray A
PROVIDER: S-EPMC3430091 | biostudies-other | 2012
REPOSITORIES: biostudies-other
Parray Aijaz A Siddique Hifzur R HR Nanda Sanjeev S Konety Badrinath R BR Saleem Mohammad M
Biologics : targets & therapy 20120817
The treatment landscape for patients with castration-resistant prostate cancer (CRPC) is undergoing significant changes with the advent of new therapies and multidisciplinary efforts by scientists and clinicians. As activation of multiple molecular pathways in the neoplastic prostate makes it impossible for single-target drugs to be completely effective in treating CRPC, this has led to combination therapy strategy, where several molecules involved in tumor growth and disease progression are tar ...[more]